VaxAlta
Edmonton
About VaxAlta
VaxAlta is focused on developing sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics. VaxAlta also provides contract services to clients applying its proprietary platform technology toward the development of novel glycoconjugate vaccines against any pathogen (bacteria, virus, parasite, etc) where there is a unique glycan to target.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2016)
- Website: vaxalta.com
- Phone: [email protected]
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/vaxalta-3799935 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.